Bruker Corp (NASDAQ: BRKRP)

Bruker Corporation is a developer, manufacturer, and distributor of high-performance scientific instruments and analytical and diagnostic solutions. The company enables customers to explore life and materials at microscopic, molecular, and cellular levels. Its products detect, measure, and visualize structural characteristics of chemical, biological, and industrial material samples across life and materials science research, biopharmaceuticals, applied markets, microbiology, in-vitro diagnostics, and nanotechnology. Bruker’s technology platforms include magnetic resonance, mass spectrometry, gas and liquid chromatography, X-ray, microscopy, metrology, and molecular spectroscopy technologies.

Bruker generates revenue through the sale of its scientific instruments, analytical systems, diagnostic solutions, and related services. Primary products include nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) systems, preclinical imaging devices, mass spectrometry instruments, X-ray diffraction and fluorescence tools, atomic force microscopes, spatial biology platforms, and superconducting materials. The company also provides service and lifecycle support, software solutions, automation platforms, and consumables such as reagent kits and test strips. Revenue is derived from a global customer base spanning academic, government, pharmaceutical, biotechnology, clinical, industrial, and applied market sectors.

The company operates through the following segments: Bruker Scientific Instruments (“BSI”) BioSpin, BSI CALID (Chemicals, Applied Markets, Life Science, In Vitro Diagnostics, Detection), BSI NANO, and Bruker Energy & Supercon Technologies (“BEST”).

• BSI BioSpin: This segment offers innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products ranging from benchtop to ultra-high field systems. It also provides preclinical imaging solutions using MRI, PET, SPECT, CT, and MPI technologies for drug discovery and disease research. Additional divisions include Biopharma and Applied, Services and Lifecycle Support, Integrated Data Solution, and Automation, which deliver workflow integration, software platforms, and lab automation tools. Trademarked systems within this segment include the 1.2 GHz NMR system, FluoroType®, LiquidArray®, InGenius, BeGenius, and MOVE-T solution for dairy markets. The segment serves academic and government research facilities, pharmaceutical and biotechnology companies, and clinical and industrial laboratories.

• BSI CALID: This segment designs, manufactures, and distributes life science and applied mass spectrometry instruments, including Bruker Life Sciences Mass Spectrometry and Bruker Applied Mass Spectrometry divisions. It also provides microbiology and infection diagnostics solutions such as PCR-based molecular diagnostic tools, monoclonal antibodies, and recombinant proteins for clinical and veterinary use. The Bruker Optics division within this segment offers infrared and Raman spectroscopy and imaging systems for industrial, environmental, and CBRNE detection applications. Key trademarked technologies include timsTOF, timsOmni, timsMetabo, timsUltra Athena Ion Processor (AIP), proteoElute, MALDI-TOF, ESI-TOF, MRMS, GC-MS, LC-MS, FT-IR, NIR, PCR, Raman, QCL IR, and FluoroType® and LiquidArray® assays. The segment’s customers include pharmaceutical and biotechnology companies, contract research organizations, academic institutions, hospitals, forensic laboratories, food and beverage safety labs, environmental agencies, and government departments.

• BSI NANO: This segment comprises Bruker AXS, which provides advanced X-ray instruments including XRF, µXRF, TXRF, XRD, µCT, EDS, EBSD, S-OES, CS/ONH, STEM, and AFM systems. It also includes Bruker Nano Surfaces and Metrology for atomic force microscopy and automated metrology tools, Bruker Spatial Biology for CosMx Spatial Molecular Imager, GeoMx Digital Spatial Profiler, nCounter, Cellscape, and PaintScape technologies, and the Consolidated Fluorescence Microscopy Business Unit and Bruker Cellular Analysis Business Unit for optical fluorescence and single-cell biology tools. Trademarked platforms include CosMx, GeoMx, nCounter, Cellscape, PaintScape, IsoLight, IsoSpark, Beacon, Beacon Discovery, Canopy, and NanoString. The segment serves academic and governmental institutions, nanotechnology and semiconductor companies, raw material and industrial manufacturers, and biotechnology and pharmaceutical firms engaged in materials analysis.

• BEST: This segment designs, manufactures, and distributes superconducting materials such as low temperature superconductors (LTS) and high temperature superconductors (HTS) for use in MRI, NMR, fusion energy research, and high-energy physics applications. It offers multifilament round and rectangular LTS wires in monolithic and wire-in-channel formats, including the Bruker Rod-Restack Process (RRP®) conductor portfolio for fusion and high-energy physics. BEST also produces HTS solutions for solenoid applications in electrical and healthcare industries, and Cuponal™, an engineered copper-clad aluminum alternative to copper wire for aerospace weight savings. Additionally, the segment manufactures non-superconducting high technology tools such as synchrotron and beamline instrumentation for materials and high energy physics research. The segment supports medical, clinical, pharmaceutical, renewable energy, and environmental research through its superconducting and diagnostic technologies.

Bruker holds a strong position in the competitive scientific instrumentation industry, facing segment-specific rivals such as JEOL, Oxford Instruments, and Magritek in NMR; Danaher, Agilent, Thermo Fisher Scientific, Waters, and Shimadzu in mass spectrometry; PerkinElmer, Mediso, and MR Solutions in preclinical imaging; Rigaku, Olympus, Nikon, Zeiss, and 10x Genomics in X-ray and microscopy; and Smiths Detection in CBRNE. The company maintains competitive advantages through its proprietary technology platforms, broad product portfolio, global service network, and continuous investment in research and development, which has historically exceeded industry averages.

Bruker serves a diversified global customer base that includes academic institutions, government research facilities, pharmaceutical and biotechnology companies, contract research organizations, hospitals, clinical and forensic laboratories, food and beverage safety providers, environmental and industrial agencies, semiconductor and nanotechnology firms, and raw material manufacturers. The company does not rely on any single customer, as no individual customer accounted for more than 10% of revenue in the last three fiscal years through December 31, 2025.